Which medications can cause a normal anion gap (hyperchloremic) metabolic acidosis?

Medications That Cause Normal Anion Gap Metabolic Acidosis

The primary medications causing normal anion gap (hyperchloremic) metabolic acidosis include carbonic anhydrase inhibitors (acetazolamide, topiramate), potassium-sparing diuretics (spironolactone, amiloride, triamterene), calcineurin inhibitors (cyclosporine), hydrochloride salts of amino acids, amphotericin, and NSAIDs 1.

Mechanism and Clinical Context

Normal anion gap metabolic acidosis occurs when bicarbonate reduction is balanced by a reciprocal increase in chloride, keeping their sum unchanged 1. This differs fundamentally from high anion gap acidosis where unmeasured organic anions accumulate.

Key Medication Classes

Carbonic Anhydrase Inhibitors:

• Topiramate is particularly important as it has carbonic anhydrase inhibitor properties that can induce metabolic acidosis with elevated urine pH, hypercalciuria, and hypocitraturia 2
• This effect increases with higher doses and prolonged exposure, raising kidney stone risk 2
• Monitor serum bicarbonate levels periodically in patients on long-term topiramate therapy 2
• Case reports confirm hyperchloremic, normal anion gap metabolic acidosis develops after dose escalation and resolves with discontinuation 3

Potassium-Sparing Diuretics:

• Spironolactone decreases sodium-potassium pump activity in the distal tubule, affecting acid-base balance 4
• Amiloride and triamterene act similarly on distal tubules 5, 1
• These agents can cause hyperkalemia, especially without concurrent loop diuretics or with potassium supplementation 4

Calcineurin Inhibitors:

• Cyclosporine A induces dose-dependent hyperchloremic metabolic acidosis with hyperkalemia in renal transplant recipients 6
• Patients develop normal anion gap acidosis with urine pH <6.0 and low-normal plasma renin activity 6
• Reducing cyclosporine dose improves but may not normalize parameters; switching to alternative immunosuppression resolves the acidosis within two weeks 6

Other Agents:

• Amphotericin 1
• NSAIDs 1
• Hydrochloride salts of amino acids 1
• Toluene 1

Clinical Monitoring Approach

When evaluating metabolic acidosis in patients on these medications:

1. Calculate the anion gap [Na+ - (Cl- + HCO3-)] to distinguish normal from high anion gap acidosis
2. Check urine pH and electrolytes to assess renal acidification capacity
3. Monitor serum potassium closely, as many of these agents affect potassium homeostasis
4. Assess renal function since impaired kidney function exacerbates the problem

Important Caveats

Diuretic-Related Confusion: While loop diuretics (furosemide) and thiazides typically cause metabolic alkalosis with hypokalemia 4, 7, excessive saline administration during treatment of conditions like DKA can cause hyperchloremia and transient non-anion gap metabolic acidosis as chloride from IV fluids replaces ketoanions 8, 9. This iatrogenic hyperchloremic acidosis is biochemically transient and not clinically significant except with acute renal failure 8.

Dose-Dependency: The severity of acidosis often correlates with medication dose, as demonstrated with cyclosporine 6 and topiramate 2, 3. Dose reduction may improve but not completely resolve the acidosis.

Reversibility: Discontinuing the offending agent typically resolves the acidosis, though the timeframe varies by medication—topiramate-induced acidosis resolves relatively quickly 3, while cyclosporine may require switching to alternative therapy for complete resolution 6.